Nitric oxide involvement and neural substrates of the conditioned and innate fear as evaluated in the T-maze test in rats

Behavioural Brain Research

Volumn 189, Issue 2, 2008, Pages 341-349

  Calixto, A V ^a   Duarte, F S ^a   Moraes, C K L ^a   Faria, M S ^a   De Lima, T C M ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Basolateral amygdala; dlPAG; Fear; Lateral septum; NO; T maze

Indexed keywords

ARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR;

AMYGDALOID NUCLEUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BRAIN LATERAL VENTRICLE; BRAIN REGION; CONDITIONED REFLEX; CONTROLLED STUDY; ELEVATED PLUS MAZE TEST; EVALUATION; FEAR; MALE; MAZE TEST; NONHUMAN; OXIDATIVE STRESS; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; RAT; SEPTUM NUCLEUS; STRIA TERMINALIS; VALIDATION PROCESS;

ANALYSIS OF VARIANCE; ANIMALS; ANXIETY; AVOIDANCE LEARNING; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; ESCAPE REACTION; FEAR; MALE; MAZE LEARNING; MICROINJECTIONS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; RATS; RATS, WISTAR;

EID: 41249098183     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2008.01.018     Document Type: Article

References (64)

1. Baretta I.P., Assreuy J., and De Lima T.C.M. Nitric oxide involvement in the anxiogenic-like effect of substance P. Behav Brain Res 121 1-2 (2001) 199-205
2. Beijamini V., and Guimarães F.S. Activation of neurons containing the enzyme nitric oxide synthase following exposure to an elevated plus maze. Brain Res Bull 69 4 (2006) 347-355
3. Bertoglio L.J., Guimarães F.S., and Zangrossi Jr. H. Lack of interaction between NMDA and cholecystokinin-2 receptor-mediated neurotransmission in the dorsolateral periaqueductal gray in the regulation of rat defensive behaviors. Life Sci 17 7 (2006) 589-596
4. Calixto A.V., Vandresen N., De Nucci G., Moreno H., and Faria M.S. Nitric oxide may underlie learned fear in the elevated T-maze. Brain Res Bull 55 1 (2001) 37-42
5. Cappendijk S.L., Duval S.Y., de Vries R., and Dzoljic M.R. Comparative study of normotensive and hypertensive nitric oxide synthase inhibitors on morphine withdrawal syndrome in rats. Neurosci Lett 183 1-2 (1995) 67-70
6. Conde C.A., Costa V., and Tomaz C. Measuring emotional memory in the elevated T-maze using a training-to-criterion procedure. Pharmacol Biochem Behav 63 1 (1999) 63-69
7. Czech D.A., Jacobson E.B., LeSueur-Reed K.T., and Kazel M.R. Putative anxiety-linked effects of the nitric oxide synthase inhibitor l-NAME in three murine exploratory behavior models. Pharmacol Biochem Behav 75 4 (2003) 741-748
8. da Cruz-Höfling M.A., Zago G.M., Melo L.L., and Rapôso C. c-FOS and n-NOS reactive neurons in response to circulating Phoneutria nigriventer spider venom. Brain Res Bull 73 1-3 (2007) 114-126
9. Davis M., and Shi C. The amygdala. Curr Biol 24 10, 4 (2000) 131
10. Davis M., and Whalen P.J. The amygdala: vigilance and emotion. Mol Psychiatry 6 1 (2001) 13-34
11. De Oliveira C.L., Del Bel E.A., and Guimarães F.S. Effects of l-NOARG on plus-maze performance in rats. Pharmacol Biochem Behav. 56 1 (1997) 55-59
12. De Oliveira R.W., Del Bel E.A., and Guimarães F.S. Behavioral and c-fos expression changes induced by nitric oxide donors microinjected into the dorsal periaqueductal gray. Brain Res Bull 51 6 (2000) 457-464
13. De Oliveira R.W., Del Bel E.A., Mamede-Rosa M.L., Padovan C.M., Deakin J.F., and Guimarães F.S. Expression of neuronal nitric oxide synthase mRNA in stress-related brain areas after restraint stress. Neurosci Lett 289 2 (2000) 123-126
14. De Oliveira R.W., Del Bel E.A., and Guimarães F.S. Effects of excitatory amino acids and nitric oxide on flight behavior elicited from the dorsal periaqueductal gray. Neurosci Biobehav Rev 25 (2001) 679-685
15. De Oliveira R.W., Forestiero D., Manfrim C.M., and Guimarães F.S. Anxiolytic effect induced by nitric oxide synthase inhibitors microinjected at medial amygdala of rats. Psychopharmacology 184 2 (2006) 166-172
16. Del Bel E.A., da Silva C.A., Guimarães F.S., and Bermúdez-Echeverry M. Catalepsy induced by intra-striatal administration of nitric oxide synthase inhibitors in rats. Eur J Pharmacol 485 1-3 (2004) 175-181
17. Doyle C.A., and Slater P. Localization of neuronal and endothelial nitric oxide isoforms in human hippocampus. Neuroscience 76 2 (1997) 387-395
18. Dunn R.W., Reed T.A., Copeland P.D., and Fry C.A. The nitric oxide synthase inhibitor 7-nitroindazole displays enhanced anxiolytic efficacy without tolerance in rats following subchronic administration. Neuropharmacology 37 7 (1998) 899-904
19. Faria M.S., Muscara M.N., Moreno Jr. H., Teixeira S.A., Dias H.B., Graeff F.G., et al. Acute inhibition of the l-arginine/nitric oxide pathway induces anxiolysis in the elevated plus-maze test. Eur J Pharmacol 323 (1997) 91-94
20. Fendt M., and Fanselow M.S. The neuroanatomical and neurochemical basis of conditioned fear. Neurosci Biobehav Rev 23 (1999) 743-760
21. Forestiero D., Manfrim C.M., Guimarães F.S., and de Oliveira R.M. Anxiolytic-like effects induced by nitric oxide synthase inhibitors microinjected into the medial amygdala of rats. Psychopharmacology (Berl) 184 2 (2006) 166-172
22. Gewirtz J.C., McNish K.A., and Davis M. Lesions of the bed nucleus of the stria terminalis block sensitization of the acoustic startle reflex produced by repeated stress, but not fear-potentiated startle. Prog Neropsychopharmacol Biol Psychiatry 22 (1998) 625-848
23. Graeff F.G., Viana M.B., and Tomaz C. The elevated T-maze, a new experimental model of anxiety and memory: effect of diazepam. Braz J Med Biol Res 23 (1993) 67-70
24. Graeff F.G., Netto C.F., and Zangrossi Jr. H. The elevated T-maze as an experimental model of anxiety. Neurosci Biobehav Rev 23 (1998) 237-246
25. Guimarães F.S., De Aguiar J.C., Del Bel E.A., and Ballejo G. Anxiolytic effect of nitric oxide synthase inhibitor microinjected into the dorsal central grey. Neuroreport 5 (1994) 1929-1932
26. Guimarães F.S., Beijamini V., Moreira F.A., Aguiar D.C., and de Lucca A.C. Role of nitric oxide in brain regions related to defensive reactions. Neurosci Biobehav Rev 29 8 (2005) 1313-1322
27. Hadeishi Y., and Wood R.I. Nitric oxide synthase in mating behavior circuitry of male Syrian hamster brain. J Neurobiol 30 4 (1996) 480-492
28. Herdade K.C.P., Strauss C.V.A., Zangrossi Jr. H., and Viana M.B. Effects of medial amygdala inactivation on a panic-related behavior. Behav Brain Res 172 (2006) 316-323
29. Hitchcock J.M., and Davis M. Efferent pathway of the amygdala involved in conditioned fear as measured with the fear-potentiated startle paradigm. Behav Neurosci 105 6 (1991) 826-842
30. Kjelstrup K.G., Tuvnes F.A., Steffenach H.A., Murison R., et al. Reduced fear expression after lesions of the ventral hippocampus. Proc Natl Acad Sci 99 16 (2002) 10825-10830
31. Krukoff T.L., and Khalili P. Stress-induced activation of nitric oxide-producing neurons in the rat brain. J Comp Neurol 377 4 (1997) 509-519
32. Leza J.C., Lizasoain I., Cuéllar B., Moro M.A., and Lorenzo P. Correlation between brain nitric oxide synthase activity and opiate withdrawal. Naunyn Schmiedebergs Arch Pharmacol 353 3 (1996) 349-354
33. Lohse M.J., Forstermann U., and Schmidt H.H.W. Pharmacology of NO: cGMP signal transduction. Naunyn Schmiedebergs. Arch Pharmacol 358 (1998) 111-112
34. Mayer B., John M., Heinzel B., Werner E.R., Wachter H., Schultz G., et al. Brain nitric oxide synthase is a biopterin- and flavin-containing multi-functional oxido-reductase. FEBS Lett 288 1-2 (1991) 187-191
35. Masood A., Banerjee B., Vijayan V.K., and Ray A. Modulation of stress-induced neurobehavioral changes by nitric oxide in rats. Eur J Pharmacol 458 1-2 (2003) 135-139
36. Menard J., and Treit D. The septum and the hippocampus differentially mediate anxiolytic effects of R(+)-8-OH-DPAT. Behav Pharmacol 9 2 (1998) 93-101
37. Menard J., and Treit D. Effects of centrally administered anxiolytic compounds in animal models of anxiety. Neurosci Biobehav Rev 23 4 (1999) 591-613
38. Moncada S., and Higgs A. l-arginine-nitric oxide pathway. N Engl J Med 329 27 (1993) 2002-2012
39. Montgomery K.C. The relation between fear induced by novel stimulation and exploratory behaviour. J Comp Physiol Psychol 48 4 (1955) 254-260
40. Monzón M.E., Varas M.M., and De Barioglio S.R. Anxiogenesis induced by nitric oxide synthase inhibition and anxiolytic effect of melanin-concentrating hormone (MCH) in rat brain. Peptides 22 7 (2001) 1043-1047
41. Onstott B., Mayer B., and Beitz A.J. Nitric oxide synthase immunoreactive neurons anatomically define a longitudinal dorsolateral periaqueductal gray of rats: analysis using laser confocal microscopy. Brain Res 610 2 (1993) 3317-3324
42. Paige J.S., and Jaffrey S.R. Pharmacologic manipulation of nitric oxide signaling: targeting NOS dimerization and protein-protein interactions. Curr Top Med Chem 7 1 (2007) 97-114
43. Pitkanen A., Jolkkonen E., and Kemppainen S. Anatomic heterogeneity of the rat amygdaloid complex. Folia Morphol (Warsz) 59 1 (2000) 1-23
44. Pokk P., and Väli M. The effects of the nitric oxide synthase inhibitors on the behaviour of small-platform-stressed mice in the plus-maze test. Prog Neuropsychopharmacol Biol Psychiatry 26 2 (2002) 241-247
45. Poltronieri S.C., Zangrossi Jr. H., and De Barros V.M. Antipanic-like effect of serotonin reuptake inhibitors in the elevated T-maze. Behav Brain Res 147 1-2 (2003) 185-192
46. Prast H., and Philippu A. Nitric oxide as modulator of neuronal function. Prog Neurobiol 64 1 (2001) 51-68
47. Quirk G.J., Russo G.K., Barron J.L., and Lebron K. The role of ventromedial prefrontal cortex in the recovery of extinguished fear. J Neurosci 20 16 (2000) 6225-6231
48. Rodrigo J., Springall D.R., Uttenthal O., Bentura M.L., Abadia-Molina F., Riveros-Moreno V., et al. Localization of nitric oxide synthase in the adult rat brain. Philos Trans R Soc Lond B Biol Sci 345 1312 (1994) 175-221
49. Rosen J.B., and Schulkin J. From normal fear to pathological anxiety. Psychol Rev 105 2 (1998) 325-350
50. Santos P., Bittencourt A.S., Schenberg L.C., and Carobrez A.P. Elevated T-maze evaluation of anxiety and memory effects of NMDA/glycine-B site ligands injected into the dorsal periaqueductal gray matter and the superior colliculus of rats. Neuropharmacology 51 2 (2006) 203-212
51. Spiacci Jr. A., Kanamaru F., Guimarães F.S., and Oliveira R.M. Nitric oxide-mediated anxiolytic-like and antidepressant-like effects in animal models of anxiety and depression. Pharmacol Biochem Behav 88 3 (2008) 247-255
52. Szabo C. Physiological and pathophysiological roles of nitric oxide in the central nervous system. Brain Res Bull 41 3 (1996) 131-141
53. Teixeira R.C., Zangrossi Jr. H., and Graeff F.G. Behavioral effects of acute and chronic imipramine in the elevated T-maze model of anxiety. Pharmacol Biochem Behav 65 4 (2000) 571-576
54. Vale A.L., Green S., Montgomery A.M., and Shafi S. The nitric oxide synthesis inhibitor l-NAME produces anxiogenic-like effects in the rat elevated plus-maze test, but not in the social interaction test. J Psychopharmacol 12 3 (1998) 268-272
55. Vazdarjanova A. Does the basolateral amygdala store memories for emotional events?. Trends Neurosci 23 8 (2000) 345-346
56. Viana M.B., Tomaz C., and Graeff F.G. The elevated T-maze: a new animal model of anxiety and memory. Pharmacol Biochem Behav 49 3 (1994) 549-554
57. Vianna D.M.L., and Brandão M.L. Anatomical connections of the periaqueductal gray: specific neural substrates for different kinds of fear. Braz J Med Biol Res 36 5 (2003) 557-566
58. Vincent S.R., and Kimura H. Histochemical mapping of nitric oxide synthase in the rat brain. Neuroscience 46 4 (1992) 755-784
59. Volke V., Soosaar A., Kõks S., Bourin M., Männistö P.T., and Vasar E. 7-Nitroindazole, a nitric oxide synthase inhibitor, has anxiolytic-like properties in exploratory models of anxiety. Psychopharmacology (Berl) 131 4 (1997) 399-405
60. Wang Y.X., Lim S.L., and Pang C.C. Increase by NG-nitro-l-arginine methyl ester (l-NAME) of resistance to venous return in rats. Br J Pharmacol 114 7 (1995) 1454-1458
61. Wultsch T., Chourbaji S., Fritzen S., Kittelt S., Grünblatt E., Gerlach M., et al. Behavioural and expressional phenotyping of nitric oxide synthase-I knockdown animals. J Neural Transm Suppl. 72 (2007) 69-85
62. Zangrossi Jr. H., and Graeff F.G. Behavioral validation of the elevated T-maze, a new animal model of anxiety. Brain Res Bull 44 1 (1997) 1-5
63. Zangrossi Jr. H., Viana M.B., Zanoveli J., Bueno C., Nogueira R.L., and Graeff F.G. Serotonergic regulation of inhibitory and one-way escape in the rat elevated T-maze. Neurosci Biobehav Rev 25 7-8 (2001) 637-645
64. Zanoveli J.M., Nogueira R.L., and Zangrossi Jr. H. Chronic imipramine treatment sensitizes 5-HT1A and 5-HT2A receptors in the dorsal periaqueductal gray matter: evidence from the T-maze test of anxiety. Behav Pharmacol 16 70 (2005) 543-552